Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country United States A Randomized Phase II/III Clinical Trial to Determine Efficacy of SRC Inhibition in Ovarian Carcinoma Program Fulbright U.S. Scholar Program Program Country United Kingdom Grant Activity Type Research Discipline Medical Sciences Academic Year 2008-2009 Dates April 2009 - February 2010 Flex No Scholar type U.S. Scholar Project Title A Randomized Phase II/III Clinical Trial to Determine Efficacy of SRC Inhibition in Ovarian Carcinoma Scholar Information Grantee Liz Han Title Other Institution University of Texas MD Anderson Cancer Center Host Institutions Institution The Royal Marsden NHS Foundation Trust
A Randomized Phase II/III Clinical Trial to Determine Efficacy of SRC Inhibition in Ovarian Carcinoma Program Fulbright U.S. Scholar Program Program Country United Kingdom Grant Activity Type Research Discipline Medical Sciences Academic Year 2008-2009 Dates April 2009 - February 2010 Flex No Scholar type U.S. Scholar Project Title A Randomized Phase II/III Clinical Trial to Determine Efficacy of SRC Inhibition in Ovarian Carcinoma Scholar Information Grantee Liz Han Title Other Institution University of Texas MD Anderson Cancer Center Host Institutions Institution The Royal Marsden NHS Foundation Trust